CN1498612A — 他汀类药物新剂型
Assigned to Sinopharm Group Rongsheng Pharmaceutical Co Ltd · Expires 2004-05-26 · 22y expired
What this patent protects
本发明涉及他汀类药物的新剂型,是一种用他汀类药物加载体制成的干混悬剂。公开的他汀类药物为洛伐他汀、辛伐他汀、普伐他汀、阿托伐他汀、氟伐他汀以及以他汀类药物为主的复方制剂;公开的新制剂载体包括稀释剂或分散剂、助悬剂、抗氧剂、螯合剂、助流剂、矫味剂、矫色剂等;公开的制备方法是主药与载体采用适宜的方法混匀制成颗粒或制成粉末后过筛分装即得。经过分散、矫味等工艺,制剂具有服用方便、药物溶出度快等优点。
USPTO Abstract
本发明涉及他汀类药物的新剂型,是一种用他汀类药物加载体制成的干混悬剂。公开的他汀类药物为洛伐他汀、辛伐他汀、普伐他汀、阿托伐他汀、氟伐他汀以及以他汀类药物为主的复方制剂;公开的新制剂载体包括稀释剂或分散剂、助悬剂、抗氧剂、螯合剂、助流剂、矫味剂、矫色剂等;公开的制备方法是主药与载体采用适宜的方法混匀制成颗粒或制成粉末后过筛分装即得。经过分散、矫味等工艺,制剂具有服用方便、药物溶出度快等优点。
Drugs covered by this patent
- Zocor (simvastatin) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.